Pilot study

Home>Tag:Pilot study
Dec 2 2024

Halberd Update on WatchDawg® PTSD Treatment

By |2024-12-01T19:39:01-05:00December 2nd, 2024|Featured, Investor News, News, Update Letter|0 Comments

Next Phase Pilot Study Jackson Center, PA December 2, 2024 – Halberd Corporation (OTC-PINK: "HALB”) previously reported results of a recently concluded initial 10-person Pilot Study of volunteer veterans suffering from PTSD and possible suicidal ideation.  The results of that study can be found here.  Based on the encouraging results of that initial pilot study, ...

Oct 1 2024

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study

By |2024-11-28T06:29:43-05:00October 1st, 2024|Featured, Investor News, Press Releases|0 Comments

Ten Military Veteran Volunteers Participated in the Pilot Study Enabled by Athena GTX Health Monitoring System Jackson Center, PA October 1, 2024 – Halberd Corporation (OTC-PINK: "HALB”) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veteran participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 ...

Sep 9 2024

Halberd Corp. Issues Letter to Shareholders – Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction

By |2024-09-08T17:19:55-04:00September 9th, 2024|Featured, Investor News, Press Releases|0 Comments

Early Pilot Study Data from Veteran Volunteers is Compelling.  Part B. Jackson Center, PA September 5, 2024 – Halberd Corporation (OTC-PINK: "HALB”) We hope you have had an opportunity to check out this Press release’s Part A. This Part B supplements that release of a few days ago. As always reach out to us if ...

Go to Top